Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Insulet Corporation (NASDAQ: PODD) was $327.48 for the day, up 1.37% from the previous closing price of $323.07. In other words, the price has increased by $1.37 from its previous closing price. On the day, 0.53 million shares were traded. PODD stock price reached its highest trading level at $327.69 during the session, while it also had its lowest trading level at $322.85.
Ratios:
Our analysis of PODD’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 20.55 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 58.32. For the most recent quarter (mrq), Quick Ratio is recorded 1.79 and its Current Ratio is at 2.23. In the meantime, Its Debt-to-Equity ratio is 0.97 whereas as Long-Term Debt/Eq ratio is at 0.64.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on June 16, 2025, initiated with a Buy rating and assigned the stock a target price of $365.
On May 30, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $380.
Wolfe Research Upgraded its Peer Perform to Outperform on May 13, 2025, while the target price for the stock was maintained at $350.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 07 ’25 when Singh Prem sold 1,343 shares for $320.00 per share. The transaction valued at 429,760 led to the insider holds 4,143 shares of the business.
Singh Prem bought 1,343 shares of PODD for $429,760 on Aug 07 ’25. On Jun 13 ’25, another insider, Singh Prem, who serves as the SVP, Global Operations of the company, sold 2,327 shares for $300.05 each. As a result, the insider received 698,216 and left with 4,143 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PODD now has a Market Capitalization of 23052134400 and an Enterprise Value of 23019816960. As of this moment, Insulet’s Price-to-Earnings (P/E) ratio for their current fiscal year is 99.66, and their Forward P/E ratio for the next fiscal year is 56.25. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.20. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.77 while its Price-to-Book (P/B) ratio in mrq is 15.76. Its current Enterprise Value per Revenue stands at 9.756 whereas that against EBITDA is 48.381.
Stock Price History:
The Beta on a monthly basis for PODD is 1.36, which has changed by 0.76254034 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, PODD has reached a high of $329.33, while it has fallen to a 52-week low of $180.31. The 50-Day Moving Average of the stock is 9.40%, while the 200-Day Moving Average is calculated to be 17.50%.
Shares Statistics:
PODD traded an average of 738.33K shares per day over the past three months and 853060 shares per day over the past ten days. A total of 70.39M shares are outstanding, with a floating share count of 70.03M. Insiders hold about 0.51% of the company’s shares, while institutions hold 101.17% stake in the company. Shares short for PODD as of 1753920000 were 1754259 with a Short Ratio of 2.38, compared to 1751241600 on 2213767. Therefore, it implies a Short% of Shares Outstanding of 1754259 and a Short% of Float of 3.7900000000000005.
Earnings Estimates
The current market rating for Insulet Corporation (PODD) reflects the collective analysis of 19.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $1.33, with high estimates of $1.53 and low estimates of $1.16.
Analysts are recommending an EPS of between $4.88 and $4.45 for the fiscal current year, implying an average EPS of $4.65. EPS for the following year is $5.7, with 23.0 analysts recommending between $6.45 and $4.71.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 19 analysts. It ranges from a high estimate of $685.71M to a low estimate of $671M. As of the current estimate, Insulet Corporation’s year-ago sales were $543.9MFor the next quarter, 19 analysts are estimating revenue of $728.21M. There is a high estimate of $745M for the next quarter, whereas the lowest estimate is $710.2M.
A total of 21 analysts have provided revenue estimates for PODD’s current fiscal year. The highest revenue estimate was $2.65B, while the lowest revenue estimate was $2.6B, resulting in an average revenue estimate of $2.62B. In the same quarter a year ago, actual revenue was $2.07BBased on 23 analysts’ estimates, the company’s revenue will be $3.09B in the next fiscal year. The high estimate is $3.19B and the low estimate is $2.98B.
